![]()

CEO and Medical Director ANRI
Head, Cinical Research Group, Parkinson's Centre for Research and Treatment
Professor Frank Mastaglia graduated in medicine from the University of Western Australia (UWA) in 1964. He then went on to train at the Institute of Neurology in London and at the Regional Neurological Centre in Newcastle-upon-Tyne and the Massachusets General Hospital in Boston. From 1977-1980 he held the Chair of Experimental Neurology at the University of Newcastle-upon-Tyne.
Returning to Western Australia he was appointed Professor of Neurology and became Head of Neurology at the Sir Charles Gairdner Hospital and Head of the UWA Department of Medicine. He joined the Australian Neuro-muscular Research Institute (ANRI) in 1990, starting the first specialty Clinics for Inflammatory Muscle Diseases and Neuromuscular Disorders.
His research program over the past 40 years has investigated the causative mechanisms and treatment of neurological and muscle disorders using pathological, neurophysiological, and molecular genetic techniques.
Over the past 15 years his research has focussed on studies of genetic susceptibility in multiple sclerosis, Parkinson's disease and autoimmune muscle diseases, and on physiological mechanisms of movement disorders, brain plasticity and therapeutic brain stimulation.
He was Director of the Centre for Neurological and Neuro-muscular Disorders at the ANRI from 2000-2010 and is currently CEO and Medical Director of the ANRI and Emeritus Consultant in Neurology to the Sir Charles Gairdner Hospital.
Latest News |
- ANRI Successful again with Adjunct Assoc Prof Bruno Meloni awarded prestigious National Stroke Foundation Grant to trial Magnesium plus Mild Hypothermia as a Stroke Therapy In Vivo
- ANRI delegates at 21st Combined Biological Siences Meeting 2011 - Won prestigious prizes...."New Investigator" Prize – Dr Carl Adkin..... "Student Poster" Prize – Ms Gurkiran Kaur Flora.......
- Congratulations Prof. Steve Wilton who has had a paper published in British Medical Journal, The Lancet. The paper reports on the results of the worlds first successful trials for treating Duchenne muscular dystrophy, directed by Steve in the UK consortium....
